Ticlopidine
- Level
- Commodity
- Parent
- 51131600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131653This classification denotes a thienopyridine antiplatelet agent with the molecular formula C14H14ClNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OM90ZUW7M1, chemically known as 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine but generally known as ticlopidine, which bears US NIH Compound Identifier 5472. European Medicines Agency schedules Ticlopidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11028MIG. The term TICLOPIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules ticlopidine in its Anatomical Therapeutic Chemical (ATC) Classification. TICLOPIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ticlopidine under HS 29349990 and SITC 51579. As of Q4 2014, TICLOPIDINE remains the US FDA Preferred Term for this commodity. Ticlopidine bears US NLM identifiers UMLS ID C0040207 and NCI Concept Code C61972. SMILES: CLC1C(CN2CCC3SCCC3C2)CCCC1.
Same parent
Under 51131600 · 61Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.